1st Quarter - Report

VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
—
Expenses
$380,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to the Orphan Drug Tax Credit (no specific bills).

LobbyistCovered position, as disclosed
RACHEL WHITEFORD MACK —
MICHAEL MATTOON —
SAMANTHA VENTIMIGLIA —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

H.R. 9 Innovation Act (all provisions)

LobbyistCovered position, as disclosed
RACHEL WHITEFORD MACK —
MICHAEL MATTOON —
SAMANTHA VENTIMIGLIA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 9 (114th)

Medicare/Medicaid MMM

Issues related to rare disease and orphan disease patient access in Medicaid (no specific bills)

LobbyistCovered position, as disclosed
RACHEL WHITEFORD MACK —
MICHAEL MATTOON —
SAMANTHA VENTIMIGLIA —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to access to rare and orphan disease therapeutics under the enactment of ACA (no specific bills); Issues related to FDA regulatory pathways for pharmaceuticals (no specific bills); Issues related to the "21st Century Cures Act" Discussion Draft (no specific bills); Issues related to the "Innovation for Healthier Americans" Report (no specific bills); H.R. 209/S.139 Ensuring Access to Clinical Trials Act (all provisions)

LobbyistCovered position, as disclosed
RACHEL WHITEFORD MACK —
MICHAEL MATTOON —
SAMANTHA VENTIMIGLIA —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 139 (114th), H.R. 209 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.